Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience

Investigational New Drugs
Pierpaolo CorrealeGiorgio Giorgi

Abstract

Advanced colorectal cancer is a common disease with an high mortality rate. For four decades, pharmacological treatment of the advanced disease was based on the use of 5-fluorouracil alone or in combination with biomodulators such as folinic acid and intereferon alpha. In the last 5 years, response to therapy has been considerably ameliorated thanks to the discovery of new drugs such as oxaliplatin and CPT-11. These agents, in combination with 5-fluorouracil, according to various schedules of treatment, have reached a significant improvement of palliation, response rate and survival. Immunotherapy is an uprising modality of treatment for human cancer including colorectal carcinoma. Its rationale is based on the knowledge that tumour cells are genetically unstable and produce molecular structures which allow their recognition and destruction by the immune-surveillance system. Therefore, humoral as well as cellular compartments of the immune system can be utilized according to a "passive" strategy (e.g. monoclonal antibody administration and adoptive immunotherapy) or an "active" approach, by using different modalities of vaccine therapy. In this context, monoclonal antibodies (mAbs) and cancer vaccines are being tested for the t...Continue Reading

References

Jan 1, 1991·The Journal of Experimental Medicine·S Jung, H J Schluesener
Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A Rosenberg
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P CorrealeA R Bianco
Jan 1, 1991·Annual Review of Immunology·R M Steinman
Jan 1, 1991·Journal of Clinical Laboratory Analysis·J A ThompsonW Zimmermann
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Apr 1, 1994·Gastroenterology·G FranciniS Civitelli
Jan 1, 1996·Progress in Histochemistry and Cytochemistry·K PantelG Schlimok
Jul 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P TagliaferriA R Bianco
Oct 1, 1996·Current Opinion in Immunology·P F Robbins, Y Kawakami
Jan 1, 1997·Advances in Pharmacology·G ParmianiF Arienti
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J O'ConnellA Figueredo
Jun 11, 1999·Advances in Immunology·D BellJ Banchereau
Nov 24, 1999·Immunological Reviews·R F Wang, S A Rosenberg
Jan 5, 2000·QJM : Monthly Journal of the Association of Physicians·T R Evans, S B Kaye
Mar 3, 2001·Apoptosis : an International Journal on Programmed Cell Death·M Bellone
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L A HarshyneS M Barratt-Boyes
Apr 21, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P CorrealeG Francini
May 15, 2001·Endocrine-related Cancer·J Mendelsohn
May 26, 2001·World Journal of Urology·H HeinzerH Huland
Jun 8, 2001·International Journal of Cancer. Journal International Du Cancer·R M Zinkernagel
Jun 28, 2001·Oncogene·F O Nestle
Oct 2, 2001·Critical Reviews in Oncology/hematology·L S Schwartzberg

❮ Previous
Next ❯

Citations

May 28, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Vanessa DeschoolmeesterMarc Peeters
Jun 30, 2010·The Oncologist·Vanessa DeschoolmeesterJan B Vermorken
Jan 24, 2013·Journal of Clinical Biochemistry and Nutrition·Hiromi SakaiToshikazu Yoshikawa
Jan 19, 2016·Drug Metabolism and Pharmacokinetics·Ruolan GuGuifang Dou
Jan 1, 2011·Cancers·Hiroshi Kitamura, Taiji Tsukamoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.